Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease(REAL-CAD).

Trial Profile

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease(REAL-CAD).

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 05 May 2017

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Cardiovascular disorders; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms REAL-CAD
  • Most Recent Events

    • 31 Oct 2016 Planned End Date changed from 30 Sep 2018 to 30 Jun 2018.
    • 17 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 17 Oct 2011 Planned end date changed from 1 Jan 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top